Annual Operating Expenses
$7.63 M
NaN%
December 1, 2023
Summary
- As of February 9, 2025, CVKD annual total operating expenses is $7.63 million
- CVKD annual operating expenses is now at all-time high.
Performance
CVKD Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.46 M
-$6600.00-0.27%
September 1, 2024
Summary
- As of February 9, 2025, CVKD quarterly total operating expenses is $2.46 million, with the most recent change of -$6600.00 (-0.27%) on September 1, 2024.
- Over the past year, CVKD quarterly operating expenses has stayed the same.
- CVKD quarterly operating expenses is now -41.43% below its all-time high of $4.20 million, reached on March 31, 2023.
Performance
CVKD Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CVKD Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | 0.0% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CVKD Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -41.4% | +1342.8% |
| 5 y | 5-year | at high | at low | -41.4% | +1342.8% |
| alltime | all time | at high | at low | -41.4% | +1342.8% |
Cadrenal Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.46 M(-0.3%) |
| Jun 2024 | - | $2.47 M(+40.5%) |
| Mar 2024 | - | $1.76 M(+38.9%) |
| Dec 2023 | $7.63 M | $1.26 M(+10.6%) |
| Sep 2023 | - | $1.14 M(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $1.03 M(-75.6%) |
| Mar 2023 | - | $4.20 M(+331.8%) |
| Sep 2022 | - | $972.80 K(+101.7%) |
| Jun 2022 | - | $482.30 K(+182.9%) |
| Mar 2022 | - | $170.50 K |
FAQ
- What is Cadrenal Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cadrenal Therapeutics?
- What is Cadrenal Therapeutics quarterly operating expenses year-on-year change?
What is Cadrenal Therapeutics annual total operating expenses?
The current annual operating expenses of CVKD is $7.63 M
What is the all time high annual operating expenses for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high annual total operating expenses is $7.63 M
What is Cadrenal Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CVKD is $2.46 M
What is the all time high quarterly operating expenses for Cadrenal Therapeutics?
Cadrenal Therapeutics all-time high quarterly total operating expenses is $4.20 M
What is Cadrenal Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CVKD quarterly total operating expenses has changed by $0.00 (0.00%)